Core One Labs Inc. CLABF
Set alert
0.00 USD 0.00 0.00%
At close · Nov 2
0.0181 Day range 0.0181
0.00001 52-week range 0.0181
- YTD
- 0.00%
- 1 year
- -90.00%
- Open
- 0.0181
- Prev close
- 0.00001
- Mkt cap
- 470
- Vol
- 71.76K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0181
- High
- 0.0181
2Y chart
Signals (61)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 22, 2025 | 1 year ago |
| RSI: Oversold | Oct 6, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 17, 2025 | 1 year ago |
| SMA: Bearish | Sep 16, 2025 | 1 year ago |
| SMA: Bullish | Sep 4, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 20, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 30, 2025 | 1 year ago |
| SMA: Bearish | Jul 29, 2025 | 1 year ago |
| SMA: Bullish | Jul 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 11, 2025 | 1 year ago |
| SMA: Bearish | Jul 10, 2025 | 1 year ago |
| SMA: Bullish | Jul 3, 2025 | 1 year ago |
| SMA: Bearish | Jul 2, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 20, 2025 | 1 year ago |
| SMA: Bearish | Jun 3, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 3, 2025 | 1 year ago |
| SMA: Bullish | May 29, 2025 | 1 year ago |
| MACD: Buy Signal | May 29, 2025 | 1 year ago |
Newest 20 of 61.
News
- CSE Bulletin: Delist - Core One Labs Inc. (COOL)
- Core One Enters into Loan Agreement with Right Season Investments
- Core One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry into the International Market
- Core One Labs' Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer's and Parkinson's, Showing Potential to Outperform Current Treatment Methods
- Core One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer's and Parkinson's Disease
- Core One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass
- Core One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer's and Parkinson's Disease
- Core One Labs Enters into Letter of Intent for First Sale of Its Psychedelic Compounds
- Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin
- Core One's Vocan Files International Patent for its Breakthrough Proprietary Biosynthetic Psilocybin Production Method
Your note
Sign in to keep a note on CLABF — it syncs with the Stock Master app.